mTOR and cancer: many loops in one pathway

被引:343
作者
Efeyan, Alejo [1 ,2 ]
Sabatini, David M. [1 ,2 ,3 ]
机构
[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA
[3] MIT, Koch Inst Integrat Res Canc, Cambridge, MA 02139 USA
关键词
PROTEIN-KINASE; CELL-GROWTH; METABOLIC CHECKPOINT; MAMMALIAN TARGET; BINDING PARTNER; RAG GTPASES; COMPLEX; RAPAMYCIN; PHOSPHORYLATION; INHIBITION;
D O I
10.1016/j.ceb.2009.10.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mammalian target of rapamycin (mTOR) is a master regulator of cell growth and division that responds to a variety of stimuli, including nutrient, energy, and growth factors. In the last years, a significant number of pieces have been added to the puzzle of how mTOR coordinates and executes its functions. Extensive research on mTOR has also uncovered a complex network of regulatory loops that impact the therapeutic approaches aimed at targeting mTOR.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 58 条
[51]   An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1 [J].
Thoreen, Carson C. ;
Kang, Seong A. ;
Chang, Jae Won ;
Liu, Qingsong ;
Zhang, Jianming ;
Gao, Yi ;
Reichling, Laurie J. ;
Sim, Taebo ;
Sabatini, David M. ;
Gray, Nathanael S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (12) :8023-8032
[52]   A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition [J].
Torbett, Neil E. ;
Luna-Moran, Antonio ;
Knight, Zachary A. ;
Houk, Andrew ;
Moasser, Mark ;
Weiss, William ;
Shokat, Kevan M. ;
Stokoe, David .
BIOCHEMICAL JOURNAL, 2008, 415 :97-110
[53]   Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity [J].
Um, SH ;
Frigerio, F ;
Watanabe, M ;
Picard, F ;
Joaquin, M ;
Sticker, M ;
Fumagalli, S ;
Allegrini, PR ;
Kozma, SC ;
Auwerx, J ;
Thomas, G .
NATURE, 2004, 431 (7005) :200-205
[54]   Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 [J].
Vander Haar, Emilie ;
Lee, Seong-il ;
Bandhakavi, Sricharan ;
Griffin, Timothy J. ;
Kim, Do-Hyung .
NATURE CELL BIOLOGY, 2007, 9 (03) :316-U126
[55]   AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer [J].
Vasudevan, Krishna M. ;
Barbie, David A. ;
Davies, Michael A. ;
Rabinovsky, Rosalia ;
McNear, Chontelle J. ;
Kim, Jessica J. ;
Hennessy, Bryan T. ;
Tseng, Hsiuyi ;
Pochanard, Panisa ;
Kim, So Young ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Hoersch, Sebastian ;
Sheng, Qing ;
Gupta, Piyush B. ;
Boehm, Jesse S. ;
Reiling, Jan H. ;
Silver, Serena ;
Lu, Yiling ;
Stemke-Hale, Katherine ;
Dutta, Bhaskar ;
Joy, Corwin ;
Sahin, Aysegul A. ;
Gonzalez-Angulo, Ana Maria ;
Lluch, Ana ;
Rameh, Lucia E. ;
Jacks, Tyler ;
Root, David E. ;
Lander, Eric S. ;
Mills, Gordon B. ;
Hahn, William C. ;
Sellers, William R. ;
Garraway, Levi A. .
CANCER CELL, 2009, 16 (01) :21-32
[56]   Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity [J].
Yang, Qian ;
Inoki, Ken ;
Ikenoue, Tsuneo ;
Guan, Kun-Liang .
GENES & DEVELOPMENT, 2006, 20 (20) :2820-2832
[57]   Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin [J].
Yu, Ker ;
Toral-Barza, Lourdes ;
Shi, Celine ;
Zhang, Wei-Guo ;
Lucas, Judy ;
Shor, Boris ;
Kim, Jamie ;
Verheijen, Jeroen ;
Curran, Kevin ;
Malwitz, David J. ;
Cole, Derek C. ;
Ellingboe, John ;
Ayral-Kaloustian, Semiramis ;
Mansour, Tarek S. ;
Gibbons, James J. ;
Abraham, Robert T. ;
Nowak, Pawel ;
Zask, Arie .
CANCER RESEARCH, 2009, 69 (15) :6232-6240
[58]   PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR [J].
Zhang, Hongbing ;
Bajraszewski, Natalia ;
Wu, Erxi ;
Wang, Hongwei ;
Moseman, Annie P. ;
Dabora, Sandra L. ;
Griffin, James D. ;
Kwiatkowski, David J. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (03) :730-738